2m 2m 2m 2m 2m 2m 2m
Exelixis (EXEL)
NASDAQ
$53.28+$0.25 (+0.46%)
Price as of Aug 03, 2026 4:53 AM EDT- $13.3BMarket Cap
- 42.32%1-Year Change
- BiotechnologyIndustry
Exelixis (EXEL)
$53.28+$0.25 (+0.46%)
Earnings Score
Valuation | EXEL | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | EXEL | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 20.10% | ||
12-Month Momentum | 48.98% | ||
3-Month Risk Adjusted Momentum | 118.83% | ||
12-Month Risk Adjusted Momentum | 144.09% |
True Yield
Valuation | EXEL | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 9.20% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | EXEL | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 12 |